Aehr Test Systems (AEHR)
NASDAQInformation TechnologySemiconductorsSnapshot 2026-09-04
$86.26+13.10%
Close 2026-09-04 · 1-day change
NASDAQInformation TechnologySemiconductorsSnapshot 2026-09-04
QuarterlyIQ Insights · AEHR
How strong the business is — where it ranks within its sector on capital efficiency and cash generation, and how well management has been executing.
How this business ranks within information technology on a research-validated quality screen. As of 2026-09-04.
The screen ranks AEHR against its sector on four durable signals: share dilution, return on capital, free-cash-flow yield, and FCF margin. Historically the highest-quality names tended toward better typical outcomes and fewer bad years over multi-year holds (strongest at three years, modest at one), and that pattern showed up even before the price moved. It characterizes business quality, not price direction.
Each leg is a sector-relative percentile (higher is better); 4 of 4 legs were available for this name. The composite is built from these four; the raw value follows each percentile for context.
A forward quality tilt, not a price prediction, and context for your own research rather than a recommendation. Not investment advice.
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Operating income rose in 2 of the last 3 quarter-over-quarter moves. Historically, Information Technology names rated neutral grew net income 55% of the time over the next year (vs 56% for the rest of the cohort, n=8445).
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A guidance track record builds as the company issues and delivers on guidance.
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
Drive significant revenue growth in fiscal 2027, targeting $130 million to $150 million, representing approximately 160%-200% year-over-year growth based on backlog and customer demand.
Stated as a priority in 3 of last 3 quarters. Revenue grew from $10.3 million in 2026-Q3 to $18.8 million in 2026-Q4, with fiscal 2026 full-year revenue at $50.0 million. Management projects fiscal 2027 revenue between $130 million and $150 million, representing 160%-200% growth year-over-year, indicating delivery on growth momentum.
“Projected fiscal 2027 revenue of $130 million to $150 million, representing expected year-over-year growth of approximately 160% to 200%.”
“Strong backlog and bookings position us to deliver significant revenue growth in fiscal 2027.”
“Bookings in second half expected between $60 million and $80 million, setting stage for strong fiscal 2027.”
Target non-GAAP net income to be 18% to 22% of total revenue in fiscal 2027, improving profitability from prior years' losses.
Stated in 2 of last 3 quarters. Fiscal 2026 non-GAAP net income was $0.9 million, improving from prior GAAP net losses. Management targets non-GAAP net income margin of 18%-22% of revenue in fiscal 2027, indicating a focus on profitability improvement, with trajectory showing progress but still early in delivery.
“Aehr expects non-GAAP net income to be 18% to 22% of total revenue in fiscal 2027.”
Complete and utilize the $60 million at-the-market equity offering to support capital allocation and growth initiatives.
Stated in 2 of last 3 quarters. The company completed an equity offering raising approximately $60 million by 2026-Q3, providing capital for allocation. This capital raise was fully executed as planned, indicating delivery on this capital allocation priority.
Maintain revenue guidance between $25 million and $30 million for fiscal year 2026 as reiterated in multiple disclosures.
Maintain non-GAAP net loss per diluted share guidance between $(0.09) and $(0.05) for fiscal year 2026.
Over the trailing year it converted 1.27x of net income into operating cash flow. Historically, Information Technology names rated neutral grew net income 57% of the time over the next year (vs 52% for the rest of the cohort, n=4162).
Most sensitive to the broad stock market.
Not enough signal to read sensitivity to the US dollar, Fed net liquidity, real (inflation-adjusted) rates, long-term interest rates (low R² over the window).
4 material management or governance events in the past 24 months, led by executive changes. Historically, Information Technology names rated stable grew net income 54% of the time over the next year (vs 60% for the rest of the cohort, n=2709).
Not investment advice. As of 2026-09-04.
“Non-GAAP net income guidance for fiscal 2026 second half and outlook for improvement.”
“Completed sales of shares with aggregate gross proceeds of approximately $60 million under equity offering program.”
“Entered into equity distribution agreement to offer and sell up to $60 million of common stock.”